Test License [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2018-10-07 23:04 (1702 d 15:51 ago) – Posting: # 19414
Views: 1,624

Dear RK,

❝ I applied Test license for some X drug in India, I got permission and I imported the drug (reference) from outside India then conducted one study (pilot). Now I want to conduct one more study (pivotal) with remaining quantity of Reference drug from first study. Here I have some doubts:

❝ 1) Can I use remaining quantity of reference drug for pivotal

No, You can't use the rest of the reference drug for conducting a BE Study with a new ordered reference drug batch, as they are two different Batches ( Biobatches).

❝ 2) If we use remaining IPs, Is we need to get Test license permission for pivotal.

Yes, you will need.




Complete thread:

UA Flag
 Admin contact
22,618 posts in 4,741 threads, 1,611 registered users;
33 visitors (1 registered, 32 guests [including 10 identified bots]).
Forum time: 14:55 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance.    Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz